Cardinal Health, Inc.

Cardinal Health, Inc.(CAH)の株式分析

$253.710

+6.114 (+2.41%)終値時点

Loading chart…
高値
254.000
始値
252.000
出来高加重平均価格
252.33
出来高
2.06M
時価総額
24.26B
安値
249.270
売買代金
518.65M
EV/EBITDA(TTM)
12.88

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

AI分析 of Cardinal Health, Inc. (CAH)

買い

Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.

アナリスト評価(16)

-11.25% 下落余地
中立
1 買い
15 中立
0 売り
現在: 253.71
安値
209.00
平均
225.18
高値
244.00

RBC Capital

2026-08-19

目標株価

$276

アウトパフォーム

TD Cowen

2026-08-13

目標株価

$280

買い

JPMorgan

2026-08-13

目標株価

$260

中立

Barclays

2026-08-13

目標株価

$275

オーバーウェイト

Morgan Stanley

2026-08-12

目標株価

$265

オーバーウェイト

バリュエーション指標

Cardinal Health, Inc.(CAH)の現在の予想PERは17.70で、5年平均は14.28です。

予想PER

割高
5年平均 P/E
14.28
現在のP/E
17.70
割高
17.21
割安
11.36

予想EV/EBITDA

割高
5年平均 EV/EBITDA
9.71
現在のEV/EBITDA
12.88
割高
11.94
割安
7.49

予想PSR

大幅な割高
5年平均 P/S
0.12
現在のP/S
0.20
割高
0.16
割安
0.09

Alphio AI による CAH の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%CAH

$146.16

シナリオ価格

基

基本

基本 · 50%CAH

$128.79

シナリオ価格

弱

弱気

弱気 · 25%CAH

$107.97

シナリオ価格

CAH を保有するクジラ

M

Martingale Asset Management, L.P.

+ を保有CAH

+8.38%

3か月リターン

V

Voleon Capital Management LP

+ を保有CAH

+7.24%

3か月リターン

O

Osmosis Investment Management UK Limited

+ を保有CAH

+7.21%

3か月リターン

N

Numeric Investors LLC

+ を保有CAH

+7.04%

3か月リターン

O

Osaic Advisory Services, LLC

+ を保有CAH

+6.98%

3か月リターン

K

Kepler Cheuvreux SA

+ を保有CAH

+6.69%

3か月リターン

イベントタイムライン

2026-10-01 (ET)

16:30:00

Major Averages Little Changed as Micron Reports Strong Q4 Earnings

12:00:00

Major Averages Decline as Treasury Yields Rise

07:00:00

Cardinal Health Extends Agreement with CVS Health to June 30, 2032

07:00:00

Cardinal Health Reaffirms FY 2027 EPS Guidance

2026-08-12 (ET)

08:30:00

Keurig Dr Pepper Appoints Aaron Alt as Director

ニュース

CAH のよくある質問 — Alphio AI が回答

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.

16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める